These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18329382)

  • 1. HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.
    Cristillo AD; Galmin L; Restrepo S; Hudacik L; Suschak J; Lewis B; Draghia-Akli R; Aziz N; Weiss D; Markham P; Pal R
    Biochem Biophys Res Commun; 2008 May; 370(1):22-6. PubMed ID: 18329382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.
    Cristillo AD; Weiss D; Hudacik L; Restrepo S; Galmin L; Suschak J; Draghia-Akli R; Markham P; Pal R
    Biochem Biophys Res Commun; 2008 Feb; 366(1):29-35. PubMed ID: 18036339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
    Cristillo AD; Lisziewicz J; He L; Lori F; Galmin L; Trocio JN; Unangst T; Whitman L; Hudacik L; Bakare N; Whitney S; Restrepo S; Suschak J; Ferrari MG; Chung HK; Kalyanaraman VS; Markham P; Pal R
    Virology; 2007 Sep; 366(1):197-211. PubMed ID: 17499328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA.
    Nimal S; Heath AW; Thomas MS
    Vaccine; 2006 Apr; 24(16):3298-308. PubMed ID: 16464521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
    Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
    J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study on immune responses induced in mice by gp120 gene vaccine of Chinese HIV-1 strain].
    Wang FX; Sun YT; Sun YN; Xu Z; Wang LX; Bai XF; Huang CX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):282-5. PubMed ID: 15193218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
    Bower JF; Li Y; Wyatt R; Ross TM
    Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy.
    Stambas J; Brown SA; Gutierrez A; Sealy R; Yue W; Jones B; Lockey TD; Zirkel A; Freiden P; Brown B; Surman S; Coleclough C; Slobod KS; Doherty PC; Hurwitz JL
    Vaccine; 2005 Mar; 23(19):2454-64. PubMed ID: 15752831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity.
    Shimada M; Yoshizaki S; Jounai N; Kondo A; Ichino M; Ryo A; Okuda K
    Vaccine; 2010 Jul; 28(31):4920-7. PubMed ID: 20566393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost".
    Wang Z; Wang SX; Liu SY; Bao ZY; Zhuang DM; Li L; Zhang CH; Zhang L; Li JY; Lu S
    Chin Med J (Engl); 2009 Oct; 122(19):2339-45. PubMed ID: 20079137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse strain-dependent differences in enhancement of immune responses by C3d.
    Toapanta FR; Ross TM
    Vaccine; 2004 Apr; 22(13-14):1773-81. PubMed ID: 15068861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector.
    Jiang W; Jin N; Cui S; Li Z; Zhang L; Wang H; Han W
    J Virol Methods; 2006 Sep; 136(1-2):1-7. PubMed ID: 16793146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
    Gavioli R; Cellini S; Castaldello A; Voltan R; Gallerani E; Gagliardoni F; Fortini C; Cofano EB; Triulzi C; Cafaro A; Srivastava I; Barnett S; Caputo A; Ensoli B
    Vaccine; 2008 Jan; 26(5):727-37. PubMed ID: 18096278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
    McCormick AL; Thomas MS; Heath AW
    J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of recombinant fowlpox virus coexpressing gp120 of Chinese HIV-1 strain and IL-18 and its immunogenicity in mice].
    Jiang WZ; Jin NY; Li ZJ; Zhang LS; Han WY
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):337-41. PubMed ID: 15971601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
    Huang Y; Chen A; Li X; Chen Z; Zhang W; Song Y; Gurner D; Gardiner D; Basu S; Ho DD; Tsuji M
    Vaccine; 2008 Mar; 26(15):1807-16. PubMed ID: 18329757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.